The Incidence and Characteristics of Thrombosis in Patients with Immune thrombocytopenia: A Retrospective Cohort Study

Ping ZhangDepartment of Hematology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information

Yanan CaiDepartment of Hematology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information

Fei GeDepartment of Hematology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information

Zunmin ZhuDepartment of Hematology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information

Kai SunDepartment of Hematology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Pages 2021-2027 | Received 08 Mar 2024, Accepted 18 Apr 2024, Published online: 08 May 2024

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386–2393. doi:10.1182/blood-2008-07-162503
PubMed Web of Science ®Google Scholar
Cines DB, Blanchette VS. Immune thrombocytopenic purpura. New Engl J Med. 2002;346(13):995–1008. doi:10.1056/NEJMra010501
PubMed Web of Science ®Google Scholar
Cines DB, Liebman HA. The immune thrombocytopenia syndrome: a disorder of diverse pathogenesis and clinical presentation. Hematol Oncol Clin North Am. 2009;23(6):1155–1161. doi:10.1016/j.hoc.2009.09.003
PubMed Web of Science ®Google Scholar
Severinsen MT, Engebjerg MC, Farkas DK, et al. Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. Br J Haematol. 2011;152(3):360–362. doi:10.1111/j.1365-2141.2010.08418.x
PubMed Web of Science ®Google Scholar
Nørgaard M, Severinsen MT, Lund Mægbæk M, et al. Risk of arterial thrombosis in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. Br J Haematol. 2012;159(1):109–111. doi:10.1111/j.1365-2141.2012.09231.x
PubMed Web of Science ®Google Scholar
Sarpatwari A, Bennett D, Logie JW, et al. Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database. Haematologica. 2010;95(7):1167–1175. doi:10.3324/haematol.2009.018390
PubMed Web of Science ®Google Scholar
Rodeghiero F. Is ITP a thrombophilic disorder? Am J Hematol. 2016;91(1):39–45. doi:10.1002/ajh.24234
PubMed Web of Science ®Google Scholar
Ruggeri M, Tosetto A, Palandri F, et al. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors. J Thromb Haemost. 2014;12(8):1266–1273. doi:10.1111/jth.12636
PubMed Web of Science ®Google Scholar
Langeberg WJ, Schoonen WM, Eisen M, et al. Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies. Int j Hematol. 2016;103(6):655–664. doi:10.1007/s12185-016-1974-6
PubMed Web of Science ®Google Scholar
Mititelu A, Onisâi M-C, Roșca A, et al. Current understanding of immune thrombocytopenia: a review of pathogenesis and treatment options. Int J Mol Sci. 2024;25(4):2163. doi:10.3390/ijms25042163
PubMed Web of Science ®Google Scholar
Aledort LM, Hayward CPM, Chen M-G, et al. Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. Am J Hematol. 2004;76(3):205–213. doi:10.1002/ajh.20104
PubMed Web of Science ®Google Scholar
Doobaree IU, Nandigam R, Bennett D, et al. Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis. Eur J Haematol. 2016;97(4):321–330. doi:10.1111/ejh.12777
PubMed Web of Science ®Google Scholar
Huang YT, Liu XF, Chen YF, et al. 原发免疫性血小板减少症患者血栓发生情况及相关危险因素分析 [The incidence and risk factors for thrombosis in primary immune thrombocytopenia]. Zhonghua Xue Ye Xue Za Zhi. 2018;39(11):942–946. Chinese. doi:10.3760/cma.j.issn.0253-2727.2018.11.014
PubMedGoogle Scholar
Tărniceriu CC, Hurjui LL, Florea ID, et al. Immune thrombocytopenic purpura as a hemorrhagic versus thrombotic disease: an updated insight into pathophysiological mechanisms. Medicina. 2022;58(2):211. doi:10.3390/medicina58020211
PubMedGoogle Scholar
Swan D, Newland A, Rodeghiero F, et al. Thrombosis in immune thrombocytopenia - current status and future perspectives. Br J Haematol. 2021;194(5):822–834. doi:10.1111/bjh.17390
PubMed Web of Science ®Google Scholar
Lafaurie M, Maquet J, Baricault B, et al. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study. Br J Haematol. 2021;195(3):456–465. doi:10.1111/bjh.17709
PubMed Web of Science ®Google Scholar
Ito S, Fujiwara S-I, Ikeda T, et al. Evaluation of thrombotic events in patients with immune thrombocytopenia. Ann Hematol. 2020;99(1):49–55. doi:10.1007/s00277-019-03886-6
PubMed Web of Science ®Google Scholar
Song F, Al-Samkari H. Management of Adult Patients with Immune Thrombocytopenia (ITP): a review on current guidance and experience from clinical practice. J Blood Med. 2021;12:653–664. doi:10.2147/JBM.S259101
PubMed Web of Science ®Google Scholar
Napolitano M, Saccullo G, Marietta M, et al. Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus. Blood Transfusion. 2019;17(3):171–180. doi:10.2450/2018.0143-18
PubMed Web of Science ®Google Scholar
Pishko AM, Misgav M, Cuker A, et al. Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. J Thromb Thrombol. 2018;46(1):24–30. doi:10.1007/s11239-018-1649-7
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The Incidence and Characteristics of Thrombosis in Patients with Immune thrombocytopenia: A Retrospective Cohort Study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The Incidence and Characteristics of Thrombosis in Patients with Immune thrombocytopenia: A Retrospective Cohort Study

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date